Vera Therapeutics (VERA) Stock Price

Vera Therapeutics Price

NASDAQ·CLOSED
28.99
​
Market closed

Analysts set a median price target of 87.00 USD, implying 200.2% above the current price. Of 20 analysts, 18 rate the stock a buy — an overall Buy consensus.

Vera Therapeutics stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vera Therapeutics business model & stock analysis

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company is headquartered in Brisbane California, California and currently employs 49 full-time employees. The company went IPO on 2021-05-14. The firm is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Its product candidate, atacicept, is a self-administered fusion protein that blocks both a B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL) which stimulates B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. Atacicept is being developed for the treatment of immunoglobulin A nephropathy (IgAN), a rare autoimmune disease that can lead to dialysis, kidney transplant, serious disease, and early death. The firm is also engaged in developing MAU868, a monoclonal antibody designed to neutralize infection with BK Virus, a polyomavirus that can have devastating consequences in certain settings such as kidney transplants.

Frequently asked questions about Vera Therapeutics

Analysts currently set an average price target of 86.75 USD for the Vera Therapeutics stock (median: 87.00 USD), implying +199.3 % versus the latest price. The consensus is based on 20 analyst ratings.

20 analysts currently rate the Vera Therapeutics stock: 18 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Vera Therapeutics to generate revenue of 24.14 M USD and earnings per share of -6.80 USD.

Converted at the current exchange rate, the Vera Therapeutics share trades at 25.84 EUR (28.99 USD).

The Vera Therapeutics share (VERA) is listed on 1 stock exchanges, including: NASDAQ (VERA).

The expected revenue of Vera Therapeutics is 24.14 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Vera Therapeutics is -437.05 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Vera Therapeutics is currently -4.26. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Vera Therapeutics stock.

The price-to-sales ratio (P/S) of Vera Therapeutics is currently 77.12. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Vera Therapeutics stock.

The Eulerpool Quality Score for Vera Therapeutics is 2/10.

The ISIN of Vera Therapeutics is US92337R1014. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Vera Therapeutics is VERA. The ticker symbol is used to trade Vera Therapeutics shares on the stock exchange.

Fair ValueTerminal
25.80 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website veratx.com
Currency
USD
Initial public offering
May 14, 2021
ISIN
US92337R1014
Cusip
92337R101
Market capitalization
2.03 B USDMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-4.26
P/Ee 2027
-6.25
P/Ee 2028
-47.73
P/Ee 2029
11.54
P/Ee 2030
4.84
P/Se
77.12
EV/EBIT
—
P/B Ratio
3.36
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-44.07 %
Last updated Oct 23, 2026, 7:59 PM

Vera Therapeutics Peer Group

Vera Therapeutics Ticker

NASDAQ · VERA

Vera Therapeutics FIGI

VERA:US · BBG00Q72WYG3VERA:UA · BBG010CJ1D76VERA:UC · BBG010CJ1D85VERA:UN · BBG010CJ1DB1VERA:UP · BBG010CJ1DC0VERA:UQ · BBG010CJ1DD9VERA:UB · BBG010CJ1DF7VERA:UM · BBG010CJ1DH5VERA:UX · BBG010CJ1DJ3VERA:UD · BBG010CJ1DP6VERA:UF · BBG010CJ1DS3VERA:VY · BBG010CJ1DT2